Loading
Teng-Yi Huang

Teng-Yi Huang

Director, R&D Medicinal Chemistry, OBI Pharma, Inc.
Teng-Yi Huang, Ph.D., is a distinguished chemist specializing in carbohydrate chemistry and its applications in Antibody Drug Conjugate (ADC) platform development. Dr. Huang is the Director of Medicinal Chemistry and the Lead of GlycOBI™ ADC Platform at OBI Pharma. He leads research efforts aimed at developing innovative therapies, particularly, next-generation ADCs. Dr. Huang's leadership has propelled the company to the forefront of ADC platform development, making OBI a leader in the field. Dr. Huang obtained his Ph.D. in Chemistry from National Tsing Hua University in Taiwan. He was a postdoctoral research fellow at the Genomic Research Center, Academia Sinica, Taiwan.
Sessions

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS